SEC Filings | Aligos Therapeutics

Filing date	Description	Form	View
Nov 27, 2023	EFFECT	EFFECT	9999999995-23-003451.pdf 9999999995-23-003451.rtf 9999999995-23-003451.xls View HTML
Nov 22, 2023	Report of unscheduled material events or corporate event	8-K	0001193125-23-282236.pdf 0001193125-23-282236.rtf 0001193125-23-282236.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 22, 2023	CORRESP	CORRESP	0001193125-23-282242.pdf 0001193125-23-282242.rtf 0001193125-23-282242.xls View HTML
Nov 21, 2023	UPLOAD	UPLOAD	0000000000-23-012755.pdf 0000000000-23-012755.rtf View HTML
Nov 17, 2023	Simplified registration form	S-3	0001193125-23-279833.pdf 0001193125-23-279833.rtf 0001193125-23-279833.xls View HTML
Nov 15, 2023	Report of unscheduled material events or corporate event	8-K	0001193125-23-277877.pdf 0001193125-23-277877.rtf 0001193125-23-277877.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 07, 2023	Notice of Exempt Offering of Securities	D	0001567619-23-007642.pdf 0001567619-23-007642.rtf 0001567619-23-007642.xls View HTML
Nov 07, 2023	An amendment to the SC 13G filing	SC 13G/A	0001104659-23-115332.pdf 0001104659-23-115332.rtf 0001104659-23-115332.xls View HTML
Nov 07, 2023	Initial filing by director officer or owner of more than ten percent	3	0001104659-23-115329.pdf 0001104659-23-115329.rtf 0001104659-23-115329.xls View HTML
Nov 06, 2023	Filing by person(s) reporting owned shares of common stock in a public company >5%	SC 13D	0001193125-23-271361.pdf 0001193125-23-271361.rtf 0001193125-23-271361.xls View HTML

Data provided by Kaleidoscope.